Capital Biosciences, Inc.

We are focusing on clinical applications and clients from pharmaceuticals, diagnostics biopharma, biotech, contract research organisations (CROs), biobanks, and other players. Our services are organized under four business lines: Central Lab Services, Site Management Organization, Precision Medicine and Companion Diagnostics. We provide end-to-end services including biomarker discovery, target validation, CDx assay development, commercialization, and regulatory services. We continually monitor our service and operations to assure that the highest level of compliance and quality is maintained. We are dynamically growing, expanding our worldwide capabilisties. We are committed to fostering a globally diverse workforce and a companywide culture that encourages excellence, leadership, innovation and a balance between our personal and professional lives. We provide comprehensive clinical services, study execution and consulting services covering a wide range of therapeutic fields, such as oncology, immunology, CNS, vaccines, rare diseases, and more. We offer comprehensive clinical research one-stop-shop solution for Pharma, Biotech and CRO companies.

We are thrilled to announce the newest acquisition to the BIOMEX family: SYMBIOSIS. Unlike many other CROs, we offer a full service:. For SARS-CoV-2 rapid tests alone, we are the provider that has validated the largest number of assays according to the European IVD Regulation. We can help you with this – with our years of experience in diagnostic assay validation, broad regulatory expertise, large in-house biospecimens inventory, and our own donations centers. Watch the video now and understand how and why we are empowering scientists. Manufacturing & Full Service – We are a manufacturer of human biospecimens and offer individual solutions for all kinds of diagnostic issues. Regardless of whether it concerns rare analytes or specific blood products: We produce over 90% of our blood plasma, as well as serum and plasma samples, under GLP conditions in our own donation centers and through our global networks. Biospecimens, Biomarker Services & Applications – BIOMEX is on track to provide human biosamples and premium services to the entire life sciences industry!

We are registered with the FDA, USDA and OLAW, and our clients range from small biomedical companies to pharmaceutical giants, academia, defense and government. Comparative Biosciences was founded in 1996 to provide expert scientific resources and quality service to all sectors of the biomedical and biopharmaceutical community. We offer extensive experience in GLP and non-GLP preclinical toxicology, efficacy, pharmacology, pharmacokinetics-pharmacodynamics, histopathology and safety studies on all laboratory species. Our particular areas of expertise include ocular, dermatology, fibrosis, otic/ototoxicity, wound healing, burns, stem cells, oncology, renal, ophthalmology, inflammation, immune-mediated models, cardiovascular and pulmonary studies, and infection models and devices, as well as contract histopathology, immunohistochemistry and custom model development. CBI is the industry leader in conducting difficult and unique IND-enabling research studies including those involving stem cells, stem cell and device combinations, delivery systems, diabetes and cancer therapies. We have a fully staffed, state-of-the-art, AAALAC-accredited facility that is purpose-built with both an in-house histopathology laboratory and a full-time quality assurance unit. CBI was founded in 1996 by Carol Meschter, DVM, PhD, DACVP; Dr. In 2004, we moved into our new state-of-the-art, purpose-built facilities in Sunnyvale, Calif.

To utilize our decades of experience on global basis to provide our customers with a framework of scientific integrity, dedication, innovative spirit, and uncompromising service in providing human biomaterials. Bay BioSciences provides top quality bio materials and related services to researchers and pharmaceutical companies all over the world. Bay BioSciences provides high quality, characterized, consented and documented human bio-specimens for research and development projects and is a leading global biobank offering vital products and services facilitating breakthroughs and innovations in translational medicine, genetics, drug discovery, biomarker research, companion and molecular diagnostics. Bay BioSciences procures hard to find human tissue samples from rare diseases, our product offering covers large spectrum of human tissue and biomaterials for research. Bay BioSciences deliver faster time to result, so your research is more productive and cost-effective. Bay BioSciences is a hub for a complete range of human biological tools required for drug discovery and development process. In addition to the above standard collection formats Bay BioSciences can also provide tumor specimens and bio-fluids according to your customized processing protocols and pre-defined specific collection kits.

We are able to support your scientists in a broad range of oncological conditions and therapeutic diseases which are included but not limited to the following list: allergology, autoimmune indications and conditions, benign conditions and normal controls, cardiology, dermatology, endocrinology, gastroenterology, gynecology and urology, hematology, infections (including COVID-19), lab testing remnants, neurology, ophthalmology, orthopedic, traumatology, ICU, pulmonology, reproductology, rheumatic disorders and many others. We believe our motto “Quality is our DNA” is a key success factor to accelerate the precision medicine programs for oncology, therapeutics and infectious conditions. This is the timeframe we usually need to prepare project documentation & collection kits, conduct training sessions with physicians and laboratory technicians who will participate in the study, and do other related activities. Our aim is to provide a fast and easy access to the biospecimens you need in the best way: precise clinical data, validated processing protocols, firm timelines, constant monitoring of clinical sites and principal investigators. BIOMEDICA CRO collaborates with clients from the leading research-investing countries, including the US, Canada, the UK, Germany, Japan, Italy, Israel, Switzerland, France, and many others. Zubov has over 17 years of experience in the international pharmaceutical markets. Searching in the web you may find following providers of biospecimens:. Some marketplaces may show the final service provider while others do not.

We are a hybrid CRO leveraging our vertically integrated model to build a life sciences biorepository with industry leading clinical and molecular data sets. BocaBio has been building one of the largest, multi-national, data-rich, commercial biobanks. We are passionate about transforming patients’ lives and understand that we can accomplish this by driving the science of our clients forward. BocaBio has a passionate commitment to in vitro diagnostics. Boca Bio’s vertically integrated platform with a data-centric modality provides true end to end solutions for accelerating the realization of cutting edge technological advancements. We believe that good business means a better world. With an ever-growing, multi-national biobank, BocaBio can provide researchers with a broad range of highly characterized human biospecimens across many indications. With a sharp focus on Oncology, we also collect and store specimens from cardiovascular disease, gastrointestinal diseases, neuro-degenerative disease and others.